Abstract
Src family kinases (SFKs), including Src, Fyn and Yes, play important roles in development and cancer. Despite being first discovered as the Yes-associated protein, the regulation of Yap by SFKs remains poorly understood. Here, through single-cell analysis and genetic lineage tracing, we show that the pan-epithelial ablation of C-terminal Src kinase (Csk) in the lacrimal gland unleashes broad Src signaling but specifically causes extrusion and apoptosis of acinar progenitors at a time when they are shielded by myoepithelial cells from the basement membrane. Csk mutants can be phenocopied by constitutively active Yap and rescued by deleting Yap or Taz, indicating a significant functional overlap between Src and Yap signaling. Although Src-induced tyrosine phosphorylation has long been believed to regulate Yap activity, we find that mutating these tyrosine residues in both Yap and Taz fails to perturb mouse development or alleviate the Csk lacrimal gland phenotype. In contrast, Yap loses Hippo signaling-dependent serine phosphorylation and translocates into the nucleus in Csk mutants. Further chemical genetics studies demonstrate that acute inhibition of Csk enhances Crk/CrkL phosphorylation and Rac1 activity, whereas removing Crk/CrkL or Rac1/Rap1 ameliorates the Csk mutant phenotype. These results show that Src controls Hippo-Yap signaling through the Crk/CrkL-Rac/Rap axis to promote cell extrusion.
Keywords: lacrimal gland, cell extrusion, Src, Yap, Rac1, Rap1
Introduction
SFKs are among the earliest identified and most studied oncoproteins, playing important roles in tumor progression and metastasis 1. Numerous Src substrates have been identified, including cell cycle regulators, adhesion molecules and transcription factors, contributing to cell proliferation, adhesion and motility. Src can be phosphorylated by the non-receptor tyrosine kinase Csk at the C-terminal tyrosine 527 residue, leading to conformational changes that suppress its kinase activity, whereas auto-phosphorylation by Src itself at the tyrosine 416 residue locks it into the active state 2. This negative regulation of Src by Csk is critical, as systemic knockout of Csk in mice causes neural tube defects and embryonic lethality as early as E9.5 3,4. Interestingly, ubiquitous loss of Csk in Drosophila led to overproliferation and decreased cell death, whereas mosaic Csk inactivation resulted in epithelial extrusion and apoptosis 5. The same behavior in cell extrusion has been observed in isolated Src-transformed mammalian cells within normal epithelial sheets 6, yet the underlying mechanism is poorly understood.
Lacrimal gland development begins as a thickening of the epithelium at the superior conjunctival fornix, which subsequently invades the underlying mesenchyme to form a highly branched structure during embryogenesis 7. However, the cellular identity of the lacrimal gland is not fully established until after birth, when acinar cells coalesce into closely packed clusters infiltrated by myoepithelial cells and are connected by duct cells that ultimately reach the ocular surface 8,9. Many studies have focused on the embryonic development of the lacrimal gland 7. In particular, we and others have shown that FGF signaling interacts with multiple other pathways, including BMP, EGF, Notch and Wnt, to regulate lacrimal gland budding, elongation and branching morphogenesis 10–20. In contrast, relatively little is known about the maturation and homeostasis of the lacrimal gland during the postnatal stage.
In this study, we investigated the role of Csk in lacrimal gland development. We showed that an epithelial-specific knockout of Csk did not affect branching morphogenesis during embryogenesis, but the lacrimal gland degenerated postnatally with dilated lumens lacking acinar cells. This phenotype was caused by the apical extrusion of lacrimal gland progenitors, which could be reproduced by constitutive activation of Yap at a critical time window before acinar cells are exposed to the basement membrane and rescued by the deletion of either Yap or Taz. By mutating tyrosine phosphorylation sites in Yap and Taz, we demonstrated that Src does not directly regulate Yap/Taz through tyrosine phosphorylation as previously reported 21–24. Instead, Csk deficiency led to Crk/CrkL-mediated stimulation of Rac1 and Rap1 that promoted the nuclear localization of Yap, and the Csk mutant phenotype can be rescued by the deletion of Crk/CrkL, Rac1 or Rap1. These results demonstrate that the Crk/CrkL-Rac1/Rap1-Yap/Taz axis is responsible for Src-induced cell extrusion.
Results
Genetic deletion of Csk during lacrimal gland development resulted in luminal expansion and acini loss.
To explore the role of Csk in the lacrimal gland, we generated a conditional knockout of Csk using the Le-Cre driver, which is active in ocular surface progenitor cells during embryonic development 13. This led to the induction of the R26R Cre reporter in the entire lacrimal gland epithelium, but not in the mesenchyme (Fig. 1A). Interestingly, although Le-Cre;Cskf/f (CskCKO) lacrimal glands did not display overt branching defects during embryonic development, their end buds appeared to be grossly dilated by P2 as shown by whole-mount Xgal or SMA/Krt14 staining (Fig. 1A, arrowheads). In sections, instead of forming the closely packed clusters as in the controls, the Xgal+ mutant epithelial cells encircled dilated lumens (supplementary Fig. 1A–B, arrows and arrowheads). By P21, the CskCKO mutant lacrimal glands were clearly atrophic, interspersed with numerous melanocytes (Fig. 1A, dotted line and arrowheads).
Figure 1. The epithelial-specific deletion of Csk disrupted postnatal lacrimal gland development.
(A) Driven by the epithelium-specific Le-Cre as indicated by R26R reporter activity (Xgal staining), the conditional knockout of Csk resulted in the dilation of lacrimal gland end buds (black arrowheads) at P2, evident in whole-mount staining of SMA and Krt14 (white arrowheads and dotted outlines). At P21, the atrophic lacrimal gland (dotted lines) in Le-Cre;Cskflox/flox (CskCKO) mutants contained numerous melanocytes (arrowheads). (B) Consistent with the role of Csk as the C-terminal kinase of Src, the loss of Csk expression in the expanded epithelial lumens was accompanied by the absence of Src-Y527 phosphorylation (pSrcY527) (dotted lines). (C) CskCKO mutants retained the lacrimal gland progenitor marker Pax6, E-caderin+ adherens junctions, ZO-1 tight junctions and Laminin+ basement membrane at P2. (D) In contrast to the persistent expression of myoepithelial markers p63 and SMA and ductal marker Krt19, there was a drastic reduction in the acinar marker Mist1 (arrowheads). Scale bars: 100 μm.
We next examined the molecular changes in Csk mutant lacrimal glands. In line with the specificity of the Le-Cre driver, Csk was selectively depleted in the E-cadherin-expressing epithelial cells, which also lost pSrcY527 phosphorylation (Fig. 1B, dotted lines). This confirms that Csk is indeed the obligatory kinase for the Src Y527 residue. Pax6 is a progenitor marker for the lacrimal gland epithelium, flanked by the apical Zo-1 and the basal Laminin staining, whereas Col2a1 is restricted to the mesenchyme. In P2 CskCKO mutants, these markers were found in their proper domains and the cell proliferation rate was also unchanged (Fig. 1C and supplementary Fig. 1C–G). By P4, however, although SMA/p63+ myoepithelial and Krt19+ ductal cells were observed around the dilated lumens, the acinar marker Mist1 was mostly absent in CskCKO mutants (Fig. 1D, arrowheads). Therefore, while Csk is dispensable for the branching morphogenesis of the lacrimal gland during embryonic development, it is necessary for the postnatal maturation of the acinar ductal network.
Single-cell RNAseq revealed epithelial cell extrusion and apoptosis in Csk mutant lacrimal glands.
To understand the molecular mechanisms underlying the Csk mutant phenotype, we performed single-cell RNA sequencing (scRNAseq) of P1 lacrimal glands. To avoid batch effects, control and mutant lacrimal gland cells were pooled together in library preparation after labelling with Cell Multiplexing Oligos (CMOs), which allowed later bioinformatic deconvolution of the sequencing reads. We sequenced 4,178 control and 5,853 CskCKO mutant cells at a depth of about 1,800 genes per cell (Fig. 2A). Following the Seurat workflow to reintegrate the single-cell profiles for unsupervised clustering, the major cell types were annotated in the Uniform Manifold Approximation and Projection (UMAP) plots using known lacrimal gland markers (supplementary Figs. 2 and 3) 25,26. Like a previous scRNAseq study, we observed that most neonatal lacrimal gland cells belonged to either the epithelium or mesenchyme, but the higher numbers of cells sequenced in our experiment permitted us to discern much greater heterogeneities in each population (Fig. 2B) 27. Surprisingly, the CskCKO mutant was enriched in one of the mesenchymal clusters (Mes6) compared to the control (Fig. 2C), despite our conditional knockout of Csk being targeted to the epithelium. We thus performed differential expression gene (DEG) analysis of this population, which identified a top candidate Cdkn2b highly specific to this cluster (Fig. 2D). Next, we labeled the epithelial cell lineage in the CskCKO mutant using the tdTomato-expressing Ai9 Cre reporter and showed by RNAscope in situ hybridization that Cdkn2b expression was restricted to the tdTomato+ cells. This result suggested that, despite having a transcriptional profile characteristic of mesenchymal cells, the Mes6 cluster in the CskCKO mutant was, in fact, derived from the lacrimal gland epithelium.
Figure 2. Csk mutant lacrimal glands exhibited epithelial cell extrusion and apoptosis.
(A) Schematic diagram of the multiplex scRNAseq workflow to minimize batch effect. Cell suspensions from P1 control and CskCKO mutant lacrimal gland cells were labeled with distinct CMO oligos, enabling demultiplexing by bioinformatic analysis after pooled scRNAseq. (B) The UMAP depiction of scRNAseq data. For clarity, only the epithelial and mesenchymal cell clusters were shown and the full UMAP clusters are presented in supplementary Figure 2B. (C) Although Csk was ablated only in the lacrimal gland epithelium, CskCKO mutant cells were enriched in Mesenchymal cluster 6 (Mes6, circled). (D) Differential expression gene (DEG) analysis and feature plot showed that Cdkn2b expression was highly specific to the Mes6 cluster. (E) Using the Ai9 reporter to follow Le-Cre expressing epithelial cells, RNAscope analysis indicated that Cdkn2b expression was restricted to the tdTomato-positive lacrimal gland epithelium (arrowheads), suggesting that Mes6 cluster cells were derived from the epithelial lineage. (F) The RNA velocity field revealed the developmental trajectories radiating from the Epi1 cluster toward other lacrimal gland epithelial cells, identifying the Epi1 cells as the progenitor population. (G) Re-clustering Mes6 cells with other epithelial cells showed that Mes6 cells are adjacent to a mixture of the Epi1 progenitors and Epi2 transitional cells. (H) Diffusion map showed the differentiation trajectories from the Epi1 progenitor cells to the acinar, myoepithelial, basal and luminal duct and Mes6 cells. (I) GSEA analysis of Mes6 cells highlighted the epithelial-mesenchymal transition and apoptosis pathways. (J) CskCKO mutant Mes6 clusters exhibited elevated apoptotic signatures. (K) Cleaved caspase 3 (c-Casp3) and TUNEL staining confirmed increased apoptosis in CskCKO mutants. Importantly, although these apoptotic cells retained the epithelial lineage marker Td, they have delaminated from the epithelium and extruded into the lumen (arrowheads). (L) Quantification of TUNEL+ cells in the lacrimal gland epithelium. Student’s t test, n=3, P<0.05. Scale bars: 200 μm.
We conducted RNA velocity analysis to map the developmental lineages and cellular dynamics of the lacrimal gland. It identified the Epi1 cluster as the initial state of the epithelial lineage (supplementary Fig. 3B), which was evident in the velocity field where the central Epi1 vectors swirled in a pattern of self-renewal, while the peripheral ones radiated out toward myoepithelial, basal duct, luminal duct and acinar cells (Fig. 2F). Since our lineage tracing experiment demonstrated that the Mes6 cells were derived from the lacrimal gland epithelium, we next reclustered the Mes6 cells with other epithelial populations, which placed the Mes6 population adjacent to the Epi2 cluster mixed with some Epi1 cells (Fig. 2G). Accordingly, the diffusion map revealed a developmental trajectory from Epi1 traversing through the Epi2 state before reaching Mes6 (Fig. 2H), suggesting that the Mes6 cells were also derived from Epi1 progenitors as other lacrimal gland epithelial cell types 28. On the other hand, gene set enrichment analysis (GSEA) identified epithelial-mesenchymal-transition (EMT) as the most prominent pathway associated with the Mes6 cluster, explaining why Mes6 cells have acquired mesenchymal characteristics. Apoptosis was another pathway significantly enriched in the Mes6 population, with CskCKO mutants displaying higher apoptosis scores than controls (Fig. 2I). This increase was confirmed by cleaved caspase-3 and TUNEL staining, which identified apoptotic cells adhering to the epithelial layers in CskCKO mutants(Fig. 2K–L). Notably, these apoptotic cells were derived from the epithelial lineages, as evidenced by their continued expression of tdTomato (Fig. 2K, arrowheads), even though there was no apoptosis within the epithelial layer itself. These observations demonstrated that these cells were extruded apically from the epithelial layer into the lumen, where they subsequently underwent apoptosis.
Csk mutant phenotype can be rescued by inactivation of Yap/Taz signaling
After uncovering a subset of lacrimal gland epithelial cells that underwent cell extrusion, we performed SCIENIC analysis to identify the transcriptional networks aberrantly activated by Csk ablation 29. One of the top Mes6-specific candidates was the Tead1 positive regulon, which was highly induced in Mes6 cells as shown by feature plots (Fig. 3A and B). The Tead family transcription factors are activated by the cofactors Yap and Taz, which undergo cytoplasmic to nuclear translocation in response to a variety of extracellular stimuli 30–32. Indeed, Yap signaling scores were most significantly increased in the Mes6 cells, but not in any other mesenchymal populations (Fig. 3C) 33. To confirm this finding, we examined the expression pattern of Yap/Taz proteins. In the control lacrimal gland, nuclear Yap-Taz staining was observed either in myoepithelial cells at the periphery of the epithelial cluster or in the duct cells at the center (Fig. 3D, arrow and arrowhead), but never in the acinar cells that made up the bulk of the E-cadherin+ epithelium (Fig. 3D, insert). In contrast, the epithelial lining of dilated lumens in CskCKO mutants consistently displayed nuclear Yap-Taz staining from P2 to the adult stage. In line with this, the Yap response gene Ccn2 (Ctgf) was sporadically expressed in the control lacrimal gland, but it was sharply upregulated in the tdTomato-labeled mutant epithelium (Fig. 3E). The ectopic Ccn2 expression in CskCKO mutants likely came from Mes6 cells since scRNAseq data showed that Ccn2 was one of the top DEGs in this population (Fig. 2D) and specifically induced in the mutant gland (Fig. 3F). These results demonstrated that the loss of Csk led to the aberrant upregulation of Yap signaling in a subset of lacrimal gland epithelial cells.
Figure 3. Yap and Taz deletion rescued Csk mutant phenotype.
(A) SCENIC analysis identified that one of the top Mes6-specific regulons in CskCKO mutant is activated by Tead1. (B) The feature plot shows the activation of the Tead1 regulon in CskCKO mutant Mes6 cluster. (C) The Yap signaling signature in the Mes6 cluster was significantly upregulated in CskCKO mutants. (D) In control lacrimal glands from P2 to P90, Yap/Taz staining was nuclear only in ductal (arrow) and myoepithelial (arrowhead) cells. In CskCKO mutants, however, nuclear Yap/Taz was detected throughout the lacrimal gland epithelia. (E) Ccn2 expression was restricted to Td-positive epithelial cells in CskCKO mutants. (F) The Yap response gene Ccn2 was highly expressed in the Mes6 cluster in CskCKO mutants. (G) Although deletion of Yap didn’t reverse Src-Y527 phosphorylation, it rescued the lacrimal gland dilation phenotype in CskCKO;YapCKO mutants (dotted lines). (H) The lumen size was quantified as the ratio of the lumen area versus the overall epithelial area. One-way ANOVA, n=5, *P<0.0001. (I) The acinar marker Mist1 was recovered in CskCKO;YapCKO mutants, except in a few mosaic epithelial cells that retained Yap nuclear expression (arrows and arrowheads in A’ and A’’), indicating the cell autonomous function of Yap responsible for the Csk mutant phenotype. (J) Deletion of either Yap or Taz in CskCKO mutants deflated Krt19 positive lumens and restored Mist1-expressing acini. (K) Quantification of Mist1+ cells. One-way ANOVA, n=5, *P<0.0001, **P<0.01. Scale bars: 100 μm.
The striking activation of Yap signaling in the lacrimal gland epithelium motivated us to ask whether it could account for the Csk mutant phenotype. To this end, we genetically ablated Yap in CskCKO mutants, which did not affect the loss of pSrcY527 phosphorylation, but suppressed the dilation of the epithelial lumen (Fig. 3G and H). This was paralleled by the recovery of Mist1 expression, indicating the rescue of acinar differentiation in CskCKO;YapCKO mutants (Fig. 3I). Considering that Cre-mediated recombination is sometimes not fully penetrant, we searched for mutant cells that may have lost Csk but not Yap. Indeed, there were occasionally enlarged lumens in CskCKO;YapCKO mutants and even isolated Mist1+ cells within acinar clusters, but they inevitably retained nuclear Yap staining (Fig. 3I, arrows and arrowheads). These genetic mosaics demonstrated that nuclear Yap acts cell autonomously to disrupt acinar development in CskCKO mutants.
Lastly, we investigated whether the genetic deletion of the Yap homolog Taz could also rescue the loss of Csk in lacrimal development. In striking contrast to dilated lumens in CskCKO mutants, CskCKO;TazCKO mutants largely maintained a normal glandular architecture consisting of compact acinar clusters surrounded by SMA+ myoepithelial cells and connected by Krt19+ ductal networks (Fig. 3J). Similar to control and CskCKO;YapCKO animals, CskCKO;TazCKO mutants also displayed abundant expression of Mist1, although the percentage of Mist1+ cells was slightly reduced (Fig. 3J and K). Given the functional redundancy between Yap and Taz, these findings suggest that the overall increase in the Yap/Taz signaling dosage is responsible for the Csk mutant lacrimal gland phenotype.
Yap activation targets the acinar progenitors unmoored from the basement membrane.
How did Csk deletion cause such a profound lacrimal gland phenotype? We first considered whether this is due to defective cell differentiation by employing a series of tissue-specific and tamoxifen-inducible Cre drivers targeting specific cell lineages: Mist1Cre-ERT2 for acinar cells, SMA-CreERT2 for myoepithelial cells and Krt7Cre-ERT2 for ductal cells (Fig. 4A) 34–36. These mutants were injected with Tamoxifen for three consecutive days from P1 to P3 and harvested at P6. The induction and specificity of each Cre driver were confirmed by either Ai9 or R26mTmG reporters, but none of these mutants exhibited any gross morphological defects (Fig. 4B). Notably, Mist1Cre-ERT2;Cskflox/flox mutants, while exhibiting an extensive loss of pSrcY527 staining except in ductal cells (Fig. 4C, dotted line), still retained Aqp5-expressing acinar cells. These findings suggest that Csk function may not be essential for terminal differentiation within specific lacrimal gland cell lineages.
Figure 4. Yap activation specifically affects the acinar progenitors when they are separated from the basement membrane.
(A) In the E17.5 lacrimal gland end bud targeted by Sox10-iCreERT2, an inner mass of acinar progenitors is insulated by an outer layer of myoepithelial progenitor cells from exposure to the basement membrane. This seal is broken in the postnatal gland where the scattered myoepithelial cells can be targeted by SMA-CreERT2, acinar cells by Mist1Cre-ERT2 and ductal cells by Krt7Cre-ERT2 . (B) The cell-type-specific induction of Mist1Cre-ERT2, Krt7Cre-ERT2 and SMA-CreERT2 was confirmed by Ai9 and R26mTmG fluorescent Cre reporters, but they did not cause a luminal dilation phenotype when crossed with the Cskflox/flox allele. (C) Mist1Cre-ERT2-mediated deletion of Csk led to the widespread loss of pSrcY527 in acinar but not ductal cells (dotted line). Nevertheless, Aqp5 expression remained unchanged. (D) Pseudotime analysis of scRNAseq data suggested that Csk deletion disrupted the differentiation of the lacrimal gland progenitor cells (Epi1) but not the end stages of Mes6, acinar and ductal cells. (E) Induction of constitutively active Yap5SA in lacrimal gland primordia by Le-Cre led to the dilation of epithelial lumens and loss of Aqp5+/Mist1+ acinar cells without affecting Pax6 and SMA expression. (F) Quantification of Mist1+ cells. Student’s t test, n=5, *P<0.0001. (G) Postnatal induction of the Yap5SA transgene by Sox10-iCreERT2 in lacrimal gland epithelial cells or by Mist1Cre-ERT2 in acinar cells as shown by the Td reporter failed to perturb lacrimal gland morphology and the expression of the acinar marker Mist1, myoepithelial marker SMA and ductal marker Krt19. (H) Tamoxifen induction of Sox10-iCreERT2;Yap5SA animals at E17.5 led to the ectopic activation of the Yap5SA transgene as indicated by the expression of nuclear localized Yap protein and LacZ reporter activity revealed by Xgal staining, resulting in luminal dilation and loss of Mist1 expression. Scale bars: 100 μm.
To understand why postnatal deletion of Csk failed to disrupt lacrimal gland development, we revisited the single-cell RNAseq data. Using Monocle to order single cells along pseudotime trajectories, we noticed that the Epi1 cluster displayed the most prominent displacement in Csk mutants, suggesting that the primary defect may lie within the epithelial progenitors (Fig. 4D) 37. To test this model, we took advantage of the R26Yap5SA allele, which can be induced by Cre to express constitutively active Yap5SA protein resistant to suppression by Hippo signaling 38. In Le-Cre;R26Yap5SA mutant lacrimal gland at P3, Pax6 and E-cadherin staining revealed dilated lumens (Fig. 4E). Although SMA+ myoepithelial cells were present, the acinar markers Aqp5 and Mist1 were lost, demonstrating that activated Yap can recapitulate the CskCKO mutant phenotype (Fig. 4E and F).
The lacrimal gland primordia consists of a Sox10− stalk that gives rise to the duct and a Sox10+ bud that differentiates into myoepithelial and acinar cells (Fig. 4A). Genetic lineage tracing has revealed that myoepithelial cells are specified by E17.5, creating a protective cap over the acinar progenitors within the bud 27,39. This effectively insulates the acinar progenitors from the surrounding basement membrane until the myoepithelial cells begin to disperse after birth. We hypothesize that this transient separation from the basement membrane during the prenatal stage distinguishes acinar progenitors from the duct and myoepithelial cells, making them particularly prone to cell extrusion due to their lack of anchorage to the basement membrane. To test this hypothesis, we first administered Tamoxifen to Sox10-iCreERT2;R26Yap5SA;Ai9 and Mist1Cre-ERT2;R26Yap5SA;Ai9 animals from P1 to P3 and analyzed them at P6 35,40. While tdTomato expression confirmed efficient induction of Sox10-iCreERT2 and Mist1Cre-ERT2 in the lacrimal gland epithelium and acinar cells, respectively, the expression of differentiation markers such as Mist1, SMA and Krt19 remained unchanged, indicating that Yap signaling does not directly regulate these genes (Fig. 4G). In contrast, when we injected pregnant dams with tamoxifen at E17.5 to activate Sox10-iCreERT2 before birth, by P4, these glands exhibited dilated lumens marked by X-gal staining, a result of a cistronic LacZ reporter from the R26Yap5SA allele (Fig. 4H, black dotted line). The epithelial linings of these enlarged lumens presented nuclear Yap staining as expected (Fig. 4H, inserts), but they have lost Mist1 expression. These results support our model that heightened Yap signaling specifically disrupts acinar progenitor development during the critical prenatal period when they are separated from the basement membrane, leading to apical extrusion and apoptosis of these vulnerable cells.
Csk-regulated tyrosine phosphorylation of Yap is dispensable for Yap function.
We next asked how the loss of Csk resulted in the activation of Yap/Taz signaling. Extensive literature has documented the close relationship between Yap and SFKs 21–24,41–45.
Mechanistically, SFKs have been shown to directly phosphorylate Yap at multiple tyrosine residues, promoting Yap cytoplasmic-nuclear shuttling and transcriptional activity 21–24. Given the essential role of Csk in regulating SFKs, we examined whether Yap tyrosine phosphorylation was upregulated by Csk deletion. To this end, we isolated mouse embryonic fibroblast (MEF) cells from Cskflox/flox embryos and infected them with Cre-expressing adenovirus (Ad-Cre). As expected, this led to the depletion of Csk, loss of inhibitory SrcY527 phosphorylation and a concomitant increase in activating SrcY416 phosphorylation (Fig. 5A). We next performed immunoprecipitation with a pan-phosphotyrosine antibody and probed for Yap protein, revealing a strong increase in Yap tyrosine phosphorylation in the absence of Csk.
Figure 5. Tyrosine phosphorylation of Yap induced by Csk deletion does not affect Yap function.
(A) Cre-mediated depletion of Csk in MEF cells led to the loss of pSrcY527 inhibitory phosphorylation and a concomitant increase in pSrcY416 activating phosphorylation without perturbing ERK phosphorylation. (B) CRISPR-Cas9 genome editing was used to mutate two tyrosine phosphorylation sites (YapY341F/Y357F or YapY2F). (C) Luminal dilation and Mist1 expression defect were not rescued in CskCKO ;YapY2F mutants. (D) Yap tyrosine phosphorylation was reduced but not lost in YapY2F homozygous MEF cells. (E) Mutating all three tyrosine residues in a Flag-tagged Yap (YapY3F) led to a complete loss of tyrosine phosphorylation as revealed by Flag or phospho-tyrosine (pY) immunoprecipitation. (F) Schematic diagram of CRISPR-Cas9 genome editing to generate YapY341F/Y357F/Y394F (YapY3F) and TazY321F (TazYF) mutant mice. (G) Yap protein remained nuclear in CskCKO ;YapY3F;TazYF mutants, resulting in luminal dilation and loss of Mist1 expression. (H) The lumen size was quantified as the ratio of the lumen area versus the overall epithelial area. One-way ANOVA, n=5, *P<0.01. (I) Quantification of Mist1+ cells. One-way ANOVA, n=5, *P<0.0001. Scale bars: 100 μm.
According to the PhosphositePlus database, the most frequently phosphorylated tyrosine residues of Yap are Y341 and Y357 (Y391 and Y407 in the Phosphosite database). We reasoned that if Csk controls Yap via Src-mediated phosphorylation, mutating these amino acids should dampen Yap activity and rescue Csk mutant lacrimal glands. We thus used CRISPR-Cas9 technology to generate point mutations in the Yap locus to replace these two tyrosine residues with phenylalanine (Fig. 5B). Surprisingly, YapY341F/Y357F(Yap2YF) mice were viable and fertile without any obvious phenotype. Examination of lacrimal glands showed that luminal dilation and acinar loss were also not rescued in CskCKO;Yap2YF mutants (Fig. 5C). This prompted us to investigate whether there was significant tyrosine phosphorylation on residues other than Y341 and Y357. Indeed, western blot analysis of immunoprecipitated Yap showed that the phosphotyrosine signal was reduced but not eliminated in Yap2YF protein (Fig. 5D). To identify the amino acid responsible for the residual tyrosine phosphorylation, we further mutated Y394 residue (Y444 in the Phosphosite database) to generate a flag-tagged YapY341F/Y357F/Y394F) (Yap3YF) protein. In line with a previous report, Yap3YF immunoprecipitated using the anti-Flag antibody lost the phosphotyrosine signal, while the anti-phosphotyrosine antibody failed to pull down Yap3YF protein (Fig. 5E) 21. Based on this result and the sequence homology between Yap and Taz, we used CRISPR-Cas9 technology to further generate Yap3YF mice and knock in the Y357F equivalent mutation in the Taz locus (TazYF) (Fig. 5F). However, neither Yap3YF nor TazYF mutant mice displayed any obvious abnormalities and even the introduction of both Yap3YF and TazYF alleles into the CskCKO background failed to prevent nuclear localization of Yap (Fig. 5G). Accordingly, CskCKO;Yap3YF;TazYF mutant glands were still composed of enlarged lumens without acinar cells (Fig. 5H and I). Through exhaustive in vivo mutagenesis, we conclusively demonstrated that tyrosine phosphorylation of Yap and Taz is a fortuitous act of Src, not responsible for the regulation of Yap/Taz signaling.
Crk and CrkL are the downstream mediators of Csk-Src signaling
If SFKs do not regulate Yap/Taz by direct tyrosine phosphorylation, there must exist intermediate factor(s) that connect the Src and Yap signaling. The DepMap consortium (depmap.org) has conducted thousands of genome-wide screens to identify the codependency of genes for cancer cell growth, providing an unbiased view of genetic relationships. We reasoned that, if we plot the codependency scores of genes shared by Src and Yap along the x and y axes, the likely intermediaries between Src and Yap would fall along a diagonal line (Fig. 6A). Remarkably, the five genes revealed by this analysis - CrkL, ILK, Rac1, RapGEF1 and Crk - are all closely linked in integrin signaling 46. Specifically, it has been shown that Src phosphorylation of the scaffold protein p130Cas leads to the recruitment of Crk and its homolog CrkL, which can bind guanine exchange factors (GEFs) Dock1 and RapGEF1 to activate small GTPases Rac1 and Rap1, respectively 47–51. This observation places the Crk/CrkL-Rac/Rap axis as the likely candidate mediating Src-Yap signaling.
Figure 6. Csk-Yap signaling was mediated by the Crk/CrkL-Rac/Rap pathway.
(A) Among the top codependency genes for both Yap and Src in Depmap data, Crk, CrkL, Rac1 and RapGEF1 fall along a diagonal axis. (B) Although PP1 is a nonselective kinase inhibitor, its bulky analog (3-IB-PP1) can only target an analog-sensitive form of Csk (CskAS) that contains an enlarged ATP-binding pocket. (C) In MEF cells that solely express CskAS mutant (CskAS; Csk−/−), the addition of 3-IB-PP1 not only elevated pSrcY416 at the expense of pSrcY527 phosphorylation, but also induced Crk phosphorylation. (D) Deletion of Crk/CrkL did not affect pSrcY527 phosphorylation, but it rescued the CskCKO luminal dilation phenotype. (E) The lumen size was quantified as the ratio of the lumen area versus the overall epithelial area. One-way ANOVA, n=5, *P<0.0001. (F) PAK-RBD pull-down assay showed that 3-IB-PP1 enhanced the GTP-bound form of Rac1. (G) CskCKO mutants exhibited a sharp increase in F-actin staining, which was diminished by the deletion of Rac1 or Rap1. (E) Quantification of F-actin staining (arbitrary unit). One-way ANOVA, n=5, *P<0.0001. **P<0.05. (I) Genetic ablation of Hippo kinases encoded by Stk3 and 4 resulted in nuclear localization of Yap, loss of pYapS127 phosphorylation and dilation of the lacrimal gland epithelium. (J) Ablation of Crk/CrkL, Rac1 and Rap1 in CskCKO mutants restored pYapS127 phosphorylation and prevented Yap nuclear localization in acinar cells. Scale bars: 100 μm.
Our hypothesis predicts that the activation of Src in the absence of Csk should lead to the recruitment of Crk/CrkL and activation of Rac1 and Rap1, but this is contradicted by previous studies that failed to detect any increase in Rac1 activity in Csk null cells 52,53. We wondered whether these conflicting results may be due to the adaptation of mutant cells to the prolonged loss of Csk. To test this idea, we deployed a chemical genetic strategy to generate acute and specific inhibition of Csk. It exploits engineered Csk protein (CskAS), which contains a gatekeeper mutation to enlarge its ATP-binding pocket, allowing it to accommodate a bulky 3-iodo-benzyl group (3-IB) attached to a highly potent but nonselective kinase inhibitor PP1 (Fig. 6B) 54. On the other hand, the 3-IB modification prevents this PP1 derivative from locking into the conserved catalytic domains, rendering it ineffective against other endogenous protein kinases. When expressed from a bacterial artificial chromosome (BAC) transgene to ensure the endogenous expression pattern, CskAS is able to support normal mouse development in CskAS;Csk−/− animals 54, demonstrating that CskAS can functionally substitute for the wild type Csk. We confirmed that MEF cells isolated from CskAS;Csk−/− animals were susceptible to acute inhibition of Csk signaling by 3-IB-PP1, which caused a rapid reduction in pSrcY527 and an increase in pSrcY416 phosphorylation without altering the level of Csk protein (Fig. 6C). Importantly, treatment with 3-IB-PP1 also led to a significant increase in pCrkY221, a known marker of Crk activity. These results showed that Csk is indeed an upstream regulator of Crk function.
To investigate whether the Crk family protein participates in Csk signaling in lacrimal gland development, we next performed a genetic rescue experiment by deleting both Crk and CrkL. Although immunostaining showed that Crk was efficiently ablated in the epithelium in Crk/CrkLCKO mutants, the lacrimal gland morphology was unaffected. However, in stark contrast to CskCKO mutants, the size of the lumens in P10 CskCKO;Crk/CrkLCKO lacrimal glands was reverted to normal despite the persistent loss of pSrcY527 phosphorylation (Fig. 6C and D). This demonstrated that Crk and CrkL are essential for Csk mutant phenotypes.
Rac1 and Rap1 suppress the Hippo-Yap pathway in response to Csk-Src signaling
Encouraged by the genetic rescue of the Csk mutant by the deletion of Crk/CrkL, we next pursued their downstream small GTPases. Notably different from previous studies in Csk−/− cells 52,53, 3-IB-PP1 treatment of CskAS;Csk−/− MEF cells led to a significant increase in the level of the GTP-bound Rac1 detected by pull-down with the RBD domain of PAK (PAK-RBD) (Fig. 6F). This showed that acute inhibition of Csk indeed led to the activation of Rac1. Consistent with the role of Rac1 in promoting actin polymerization, the CskCKO mutant lacrimal gland epithelium also exhibited a significant increase in F-actin staining, which was reversed by the deletion of Rac1 (Fig. 6G and H). Importantly, the lumen dilation phenotype was also ameliorated in CskCKO;Rac1CKO glands. On the other hand, deletion of the two Rap1 genes, Rap1a and Rap1b, in CskCKO;Rap1CKO animals similarly reduced F-actin staining and partially normalized lacrimal gland architecture. These results suggested that Rac1 and Rap1 are important mediators of Csk signaling.
The actin cytoskeleton network regulated by small GTPases plays an important role in Hippo signaling, whose mammalian orthologs Mst1/2 (encoded by Stk3/4) activate Lats1/2 kinases to prevent Yap nuclear translocation by phosphorylating multiple serine residues of Yap, especially YapS127 30,55. We thus explored the consequence of impaired Hippo signaling by ablating Stk3/4 in the lacrimal gland epithelium, which showed greatly reduced pYapS127 staining and nuclear localization of Yap as expected. Importantly, Stk3/4CKO displayed enlarged lumens like CskCKO mutants, demonstrating that the loss of Hippo signaling was sufficient to reproduce the Csk phenotype (Fig. 6I, dotted lines and inserts). Further supporting the view that the deletion of Csk may disrupt Hippo signaling, pYapS127 staining was abundant in the cytoplasm of control lacrimal gland cells, but it was completely lost in the CskCKO mutant epithelium, which is the exact opposite pattern compared to Yap nuclear staining (Fig. 6J, dotted lines and inserts). Although the normal pattern of pYapS127 was not affected by the deletion of Crk/CrkL, Rac1 and Rap1 alone, it was restored in CskCKO;Crk/CrkLCKO and CskCKO;Rac1CKO acinar cells. In the partially rescued CskCKO;Rap1CKO mutants, the remaining dilated lumens inevitably lost pYapS127 staining while retaining nuclear Yap expression. These results indicate that deletion of Crk/CrkL, Rac1 and Rap1 suppressed Yap activity in the lacrimal gland by maintaining Hippo signaling. Lastly, we showed that the lumen size was normalized in CskCKO;Crk/CrkLCKO , CskCKO;Rac1CKO and, to a lesser extent, CskCKO;Rap1CKO mutants. In addition, the pattern of SMA+ myoepithelial cells and Krt19+ ducts and the quantity of Mist1/Aqp5-expressing acinar cells were similarly recovered (Fig. 7A and B). Taken together, our study demonstrated that Csk-Src signaling is transmitted via the Crk/CrkL-Rac/Rap cascade to regulate Hippo-Yap signaling in lacrimal gland development.
Figure 7. Deletion of Crk/CrkL, Rac1 or Rap1 rescued CskCKO mutant lacrimal gland phenotype.
(A) The normal glandular morphology and Mist1-expressing acini were restored after the genetic deletion of Crk/CrkL, Rac1 or Rap1 in CskCKO mutants. (B) Quantification of the lumen size and the number of Mist1+ cells. One-way ANOVA, n=5, *P<0.0001, **P<0.05. (C) The model of Csk control of Yap signaling. Csk-regulated Src kinase phosphorylates p130Cas in the Integrin-anchored focal adhesion complex to create docking sites for Crk and CrkL, which recruit GEFs for small GTPases Rac and Rap to promote F-actin formation. This in turn suppresses serine phosphorylation (pSer) of Yap by Mst-Lats signaling, leading to nuclear translocation of Yap which promotes cell extrusion and abolishes acinar differentiation. In contrast, fortuitous tyrosine phosphorylation of Yap by Src is dispensable for Yap activity. Scale bar: 100 μm.
Discussion
In the current study, we have uncovered a previously unappreciated requirement for regulating cell extrusion in lacrimal gland development. We showed that the deletion of Csk in the lacrimal gland epithelium resulted in luminal dilation and the loss of acinar cells, which originated from apoptosis of lacrimal gland progenitors caused by Src-induced cell extrusion. Through genetic analysis, we challenged the widely held belief that Src directly regulates Yap via tyrosine phosphorylation. Instead, considering the known role of Src in regulating integrin signaling by phosphorylating the p130Cas protein 1, we propose that the main function of Src is to create docking sites on p130Cas for Crk and CrkL that subsequently activate Rac and Rap to promote F-actin polymerization (Fig. 7C). This prevents Hippo signaling from suppressing the nuclear translocation of Yap and Taz to stimulate Tead transcription factors, causing expulsion of acinar progenitor cells into the lacrimal gland lumen. Our study illuminated the molecular mechanism by which Src-regulated mechanosignaling induces cell extrusion by Yap/Taz-mediated transcriptomic reprogramming.
Cell extrusion is a crucial process in development, tissue homeostasis and tumor suppression 56,57. It is a key element of the cell competition program that removes unfit cells, where mutant clones are actively eliminated by surrounding wild type, but not by other mutant cells 58,59. This is exemplified in Drosophila, where Csk knockdown in the entire eye imaginal discs resulted in organ overgrowth, but discrete inactivation of Csk in clonal patches led to epithelial extrusion and apoptotic death 5. In contrast, we found that deleting Csk throughout the lacrimal gland epithelium specifically triggers the loss of acinar cells, which extruded apically into the lacrimal gland lumen – a stark difference from the basal extrusion observed in Drosophila. To explain these discrepancies, we note that the acinar progenitors are unique among the lacrimal gland cells in their separation from the basement membrane by myoepithelial progenitors during embryonic development. Unencumbered by the integrin-mediated adhesion to the basement membrane, these acinar progenitors are receptive to mobilization by Src-activated Yap signaling to delaminate from the lacrimal gland epithelium. Supporting this model, we observed loss of acinar cells only when Yap was activated in prenatal progenitors, but not in mature lacrimal glands, coinciding with the critical period when acinar progenitors lack basement membrane anchorage. It is intriguing to note that Src is known to act in the integrin pathway to promote cell invasion and mobility by stimulating the disassembly and turnover of the focal adhesion complex. In the absence of active integrin engagement with the basement membrane, the deletion of Csk may have unleashed Src to hijack the cell motility component of the integrin pathway to promote cell extrusion. This study highlights that cell extrusion can arise not just from competition between different genotypes, but also from differences in adhesive properties and motility potential among cells harboring the same mutations.
Comprising nine members and present in all cell types, SFKs exert a profound influence across the proteome, as evidenced by the lethal outcomes of their genetic knockouts and their potency for driving oncogenic transformation 1. Although mass spectrometry analyses have shown that SFKs may phosphorylate hundreds of proteins, identifying their physiologically relevant targets remains an ongoing challenge 60,61. In the absence of Csk, unfettered SFK signaling could have pleiotropic effects through numerous downstream effectors. For example, in Drosophila, the extrusion of Csk-deficient cells in the eye is thought to be mediated by the Cadherin-JNK-MMP axis 5. In contrast, in MDCK cells, a standard mammalian model for studying cell extrusion, the process in Src- and Yap-activated cells was reported to rely on MAPK and PI3K-mTOR signaling pathways, respectively 6,62. It is thus remarkable that the striking lacrimal gland phenotypes in Csk mutants can be completely replicated by activating Yap and reversed by its deletion. This finding suggests that at least in the context of lacrimal gland development, the transcriptomic changes driven by Yap are both necessary and sufficient to mimic the broad phosphoproteomic changes caused by SFKs. Our study highlights a critical connection between these two proto-oncoproteins, potentially offering insights applicable to both developmental and cancer biology.
Yap was originally named as “Yes-associated protein” because of its binding affinity to the SFK family member Yes 63, but the biological significance of this association remains contentious in the field 64. Previous studies have posited that Src phosphorylation of Yap may control its nuclear localization 21 or transcriptional activity 22–24, but these assertions have been disputed by other research suggesting that Src regulates Yap indirectly via PI3K, JNK or tyrosine phosphorylation of Lats 41–44. Similar controversy also exists concerning Src’s regulation of Taz 65,66. These discrepancies likely arise because these studies have relied on gene overexpression, RNAi knockdown or small molecule inhibitors, which are prone to off-target artifacts and may not accurately reflect physiological conditions. Most importantly, these models are all based on in vitro cell culture systems, but were not tested rigorously in vivo. Our work helps to fill this gap by generating knock-in mice to systematically mutate tyrosine residues phosphorylated by Src in Yap and Taz. Contradicting the prevailing belief that tyrosine phosphorylation is crucial for Yap/Taz regulation, these phosphorylation-deficient animals didn’t exhibit any obvious defects in growth and fertility, nor did they rescue lacrimal gland development in the Csk mutant background. These findings lead us to conclude that, despite being observed in numerous experimental settings, tyrosine phosphorylation of Yap/Taz is not physiologically relevant to Yap signaling. Instead, we showed that the Csk lacrimal gland phenotype can be mimicked by deactivating Hippo kinases Mst1/2 and rescued by genetically ablating Crk/CrkL, Rac and Rap, which reinstates Hippo-dependent phosphorylation and cytoplasmic localization of Yap. Our mouse genetic study breaks new ground by revealing a previously unrecognized role of Crk proteins in Yap regulation, establishing a Src-Crk/CrkL-Rac/Rap molecular pathway that links Csk to Hippo signaling.
Methods and Materials
Mice
All procedures related to animal care and experimentation were conducted in adherence to the protocols and guidelines approved by the Institutional Animal Care and Use Committee at Columbia University. Mice carrying Crkflox, CrkLflox, Krt7Cre-ERT2, R26Yap5SA, Rap1aflox and Rap1bflox alleles were bred and genotyped as outlined 36,38,51,67,68. Cskflox is from Dr. Alexander Tarakhovsky (The Rockefeller University, New York, NY) 69, Le-Cre from Richard Lang (Children’s Hospital Research Foundation, Cincinnati, OH) 70, Mist1Cre-ERT2 from Timothy Wang (Columbia University, New York, NY) 34, SMA-CreERT2 from Ivo Kalajzic (University of Connecticut, Farmington, CT) 35, Rac1flox from Dr. Feng-Chun Yang (Indiana University School of Medicine, Indianapolis, IN) 71, and Ai9 (Stock #: 007908), CskAS;Csk−/− (Stock #: 025250), R26R (Stock #: 003474), Sox10-iCreERT2 (Stock #: 027651), Stk3 flox;Stk4flox (Stock #: 017635) and Yapflox;Tazflox (Stock#: 030532) from Jackson Lab. Mice were maintained on a mixed genetic background, and at least three animals were analyzed for each described cross, using Cre-heterozygous mice as controls. Tamoxifen, prepared in corn oil at 10 mg/mL and stored at 4°C, was administered via intraperitoneal injections at 100 mg/g of mouse body weight, with three consecutive injections performed to achieve maximum Cre induction.
Yap2YF, Yap3YF and TazYF mice were generated using the modified Easi-CRISPR method 72. Briefly, highly stringent gRNAs near the mutation sites were identified using online design tools (http://crispor.tefor.net) and chemically synthesized by IDT with 2’-O-methyl 3’phosphorothioate modifications and end-blocking Alt-R modifications. Single-stranded donor templates, with the desired amino acid alterations and disrupted PAM sites, along with silent mutations creating restriction enzyme sites, were injected into mouse zygotes with a pre-assembled gRNA-Cas9 enzyme complex by the transgenic facility at Columbia University Medical Center. Correctly targeted founder animals were identified through direct sequencing. The following gRNAs were used: GGAAGTCGTCTGGGGTCCGA GGG and CGAGAGTGATAGGTGCCACT AGG for Yap2YF, GGAGGGCTTCCAGGTAGTCG GGG for Yap3YF and GGAAGTCTTCTGGAGTTGTG GGG for TazYF.
Histology and immunohistochemistry
Histology and immunohistochemistry were performed on the paraffin and cryosections as previously described 73,74. For hematoxylin and eosin (H&E) staining, 10 μM paraffin sections underwent deparaffinization with histosol wash, rehydration through decreasing concentrations of ethanol solutions, and final washing in water. The slides were immersed in hematoxylin for 3 minutes, followed by a 10–15 minute wash with tap water. Subsequently, they were decolorized with 1% acid alcohol for 30 seconds before treatment with eosin for 1 minute. Samples were dehydrated through increasing ethanol concentrations, transferred to histosol, and mounted using Permount mounting medium.
For immunofluorescence staining, cryosection slides were briefly washed with PBS to remove OCT. Antigen retrieval was performed in a microwave by boiling for 1–2 minutes, followed by heating for 10 minutes at low-power settings in sodium citrate buffer (10 mM sodium citrate, pH 6.0). Sections were then washed with PBS and blocked for 30 minutes with 5% normal goat serum (NGS)/0.1% Triton in PBS. Primary antibody incubation occurred overnight at 4°C in a humid chamber, followed by incubation with fluorophore-conjugated secondary antibodies for 2 hours at room temperature in the dark.
TUNEL assays were carried out on 10 μm cryosections following the manufacturer’s protocol in the Fluorescein in Situ Cell Death Detection kit (Roche Applied Science, Indianapolis, IN).
The following primary antibodies were utilized: Aquaporin5 (abcam #ab78486), Cleaved caspase3 (CST#9662), Col2A1 (Abcam #ab34712), Crk (BD #610036), Csk (Proteintech #17720-AP), c-Src (Santa Cruz #sc-8056), E-cadherin (BD Bio #610181 and CST #3195), Keratin14 (Covance #PRB-155P), Keratin19 (DSHB #TROMA-III), Ki67 (BD #550609), Laminin (BD #354232), Mist1 (abcam #ab187978), p63 (Biolegend #619001), Pax6 (Covance #PRB-278P), Phalloidin (Life Technology #A12380), pHH3 (Millipore #06–570), pSRC527 (CST #2105), pYAP Ser127 (CST #4911), SMA (Agilent #M085129–2), Yap (CST #14074 and Santa Cruz #sc-101199), Yap-taz (CST #8418), ZO1 (DSHB #R26.4C). All commercial antibodies were validated by vendors. At least three embryos of each genotype were stained for each marker.
Single-cell RNA-seq and bioinformatic analysis
Lacrimal glands obtained from P1 pups (three for each genotype) underwent a PBS wash for 2–5 minutes and were digested with dispase (2000 units/ml) and papain (20 units/ml) for 30 minutes at room temperature. After gently removing the digestion enzyme mixture, the glands were washed with PBS and mechanically disrupted through vigorous pipetting until single-cell dispersion was observed under the microscope. Following three washes in PBS and centrifugation at 3000 rpm at 4°C, control and CskCKO mutant cells were treated with cell multiplexing oligos (CMO) in accordance with the 10x Genomics 3’ cellplex kit manual. The cells were then pooled together in a single collection tube for library preparation and subsequent sequencing at Columbia University’s single-cell sequencing core. The RNAseq data were deposited at the Gene Expression Omnibus (GEO) database (GSE253784) and single-cell portal (SCP2499).
Gene-cell matrices, generated using Cell Ranger 2.1.1 from 10x Genomics, were imported into R and analyzed using Seurat. Cells with <200 or > 4000 genes, as well as those exhibiting >15% expression of mitochondrial genes, were filtered out prior to dataset normalization and scaling. Dimensionality reduction was achieved through Principal Component Analysis (PCA) and non-linearly with Uniform Manifold Approximation and Projection (UMAP) with dimensions = 1:20. Following the integration of control and mutant datasets through canonical correlation analysis (CCA), clustering was performed using “RunUMAP” and annotated based on known marker genes. Differential gene expression testing was conducted using the “FindMarkers” and “FindAllMarkers” functions in Seurat.
A subset comprising epithelial clusters and the Mes6 cluster was extracted and re-clustered. A diffusion map of this subset was generated using the R package “destiny” 28. Trajectory analysis and pseudotime analysis for this subset were performed using the Monocle package in R 37. Gene Set Enrichment Analysis (GSEA) of hallmark pathways between control and mutant samples was calculated using the R package “fgsea.” Regulon analysis was executed using the pySCENIC packages in Python 37.
Cell culture, immunoprecipitation and western blot
Mouse embryonic fibroblast (MEF) cells were isolated from E13.5 mouse embryos. Following the removal of heads and guts with autoclaved scissors, cleaned embryos were finely chopped and incubated with trypsin for 30 minutes at 37°C. Further dissociation was achieved through vigorous pipetting, and single cells were cultured in a 10 cm cell culture dish with DMEM media containing 10% FBS. CskAS;Csk−/− MEF cells were treated with 25 μM 3IB-PP1 for 5 minutes, immediately washed with ice-cold PBS, and resuspended in lysis buffer for subsequent analysis. The Rac1-GTPase assay was performed using the Rac1 Pull-Down Activation Assay Biochem Kit (Cytoskeleton #BK-035).
Cskflox/flox MEF cells, at 60% confluency in a 15 mm dish, were incubated with Ad5-CMVCre virus (1×1010 pfu/ml, Gene Transfer Vector Core, University of Iowa, IA) at a 1:500 dilution for 5 days before being treated with 1 mM sodium orthovanadate (S6508, Sigma Aldrich) for 3 minutes at 37°C. After adding ice-cold lysis buffer (C2978, Sigma Aldrich) containing 1X protease inhibitor and 1 μM sodium orthovanadate, cells were scraped from the culture plate, collected in a 1.5 ml tube, and kept on ice for 10 minutes. Following dissociation by passing through syringe needles ten times and sonication three times with a 5-second pulse each, the cell lysate was centrifuged at 15,000 rpm for 10 minutes. The supernatant was incubated with immunoprecipitation antibodies at the suggested concentration overnight at 4°C, followed by protein A/G agarose beads (Santa Cruz Biotechnology, SC2003) for 2 hours at 4°C. The beads were collected by centrifugation at 4°C at 5000 rpm for 2 minutes and washed with ice-cold PBS in the presence of 1X protease inhibitor and 1 mM sodium orthovanadate three times for 5 minutes each. After the beads were resuspended in 40 μl of 1X Laemmli buffer and boiled at 100°C for 5 minutes, 20 μl of the supernatant was loaded onto a 12% SDS PAGE agarose gel for standard western blot analysis. Antibodies against phospho-Tyrosine (P-Tyr-100) (CST #9411), YAP (CST #14074 and Santa Cruz #sc-271134), and Flag (CST # 8146) were used for immunoprecipitation (5 μg antibody for 500 μg protein). Antibodies against Crk (BD #610036), Csk (Proteintech #17720-AP), ERK1/2 (CST #4695), pCRK (CST #3491), pERK1/2 (Santa Cruz Biotechnology, sc-7383), pSRC416 (CST #6943), pSRC527 (CST #2105), YAP (CST #14074), and phospho-tyrosine (P-Tyr-100) #9411 were used in western blot (1:1000 dilution).
Cell transfection
The plasmid encoding wild-type Yap was obtained from Addgene (pcDNA Flag Yap1, Addgene #18881). Plasmids encoding Yap2YF and Yap3YF were constructed from pcDNA Flag-Yap1 Y357F (Addgene #18882) through site-directed mutagenesis using Neb Q5 high-fidelity polymerase (New England Biolab #M0491). The primers used for Y349F were Forward: CAGTGGCACCTATCACTCTCGAGATGAG and Reverse: TTAAGGAAAGGATCTGAGCTATTG. The primers used for Y402F were Forward: TTTCCCAGACTTCCTTGAAGCCATTC and Reverse: CGGTTCTGCTGTGAGGGC.
For cell transfection, 10 μg of plasmid and 30 μg of polyethylenimine (PEI, Serochem #Prime p100) were separately incubated with 300 μl of DMEM media each for 10 minutes at room temperature. They were then mixed and gently added to 70% confluent HEK293 cells in a 10 cm culture dish with 10 ml DMEM media. After overnight incubation, the culture media was replaced with DMEM containing 10% FBS, and the transfected cells were harvested the following day.
Quantification and Statistical Analysis
Lumen sizes were quantified as the area ratios of the inner lumens versus the outer epithelium linings using Image J. For the quantification of F-actin staining, fluorescent images were converted to grayscale, and mean intensities were measured using ImageJ. To quantify Mist1 expression, cell proliferation, and apoptosis, the percentage of Mist1, Ki67, and TUNEL-positive cells were normalized against the total number of DAPI-positive cells within each epithelial cluster. At least three animals for each genotype were analyzed. Statistical analysis was performed using GraphPad Prism 7. Sample sizes were not predetermined. Data represent mean ± s.d. An unpaired two-tailed t-test was used for comparing two conditions and one-way ANOVA with Tukey’s multi-comparison test for three or more conditions.
Database Analysis
The tyrosine phosphorylation sites in Yap1 were identified from the PhosphoSitePlus database (phosphosite.org) by examining the number of references that uncovered phosphorylation events in each tyrosine residue.
The top codependencies for Yap1 and Src were retrieved from the Depmap database (Public 23Q4+Score, Chronos) at depmap.org, and plotted in a 2-D chart. Genes with similar codependency scores to both Yap1 and Src were identified as lying within two diagonal lines bisecting the plot.
Supplementary Material
Acknowledgements
The authors thank Drs. Ruth Ashery-Padan, Tom Curran, Ivo Kalajzic, Richard Lang, Lawrence A Quilliam, Feng-Chun Yang, Alexander Tarakhovsky and Timothy Wang for mice and reagent. The work was supported by grants from NIH (R01EY018868 and R01EY031210 to X.Z. and R01HL152293 to J.Q.). Q.W. is supported by a Pathway to Independence Award (K99EY032171) and N.M. is supported by a Knights Templar Eye Foundation Career Starter Grant Award. The Columbia Ophthalmology Core Facility is supported by NIH Core grant 5P30EY019007 and unrestricted funds from Research to Prevent Blindness (RPB).
References
- 1.Yeatman T. J. A renaissance for SRC. Nature reviews. Cancer 4, 470–480, doi: 10.1038/nrc1366 (2004). [DOI] [PubMed] [Google Scholar]
- 2.Okada M. Regulation of the SRC family kinases by Csk. Int J Biol Sci 8, 1385–1397, doi: 10.7150/ijbs.5141 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Imamoto A. & Soriano P. Disruption of the csk gene, encoding a negative regulator of Src family tyrosine kinases, leads to neural tube defects and embryonic lethality in mice. Cell 73, 1117–1124 (1993). [DOI] [PubMed] [Google Scholar]
- 4.Nada S. et al. Constitutive activation of Src family kinases in mouse embryos that lack Csk. Cell 73, 1125–1135 (1993). [DOI] [PubMed] [Google Scholar]
- 5.Vidal M., Larson D. E. & Cagan R. L. Csk-deficient boundary cells are eliminated from normal Drosophila epithelia by exclusion, migration, and apoptosis. Dev Cell 10, 33–44, doi: 10.1016/j.devcel.2005.11.007 (2006). [DOI] [PubMed] [Google Scholar]
- 6.Kajita M. et al. Interaction with surrounding normal epithelial cells influences signalling pathways and behaviour of Src-transformed cells. Journal of cell science 123, 171–180, doi: 10.1242/jcs.057976 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Garg A. & Zhang X. Lacrimal gland development: From signaling interactions to regenerative medicine. Dev Dyn 246, 970–980, doi: 10.1002/dvdy.24551 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Zoukhri D. Mechanisms involved in injury and repair of the murine lacrimal gland: role of programmed cell death and mesenchymal stem cells. Ocul Surf 8, 60–69 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Dartt D. A. Neural regulation of lacrimal gland secretory processes: relevance in dry eye diseases. Prog Retin Eye Res 28, 155–177, doi: 10.1016/j.preteyeres.2009.04.003 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Entesarian M. et al. Mutations in the gene encoding fibroblast growth factor 10 are associated with aplasia of lacrimal and salivary glands. Nat Genet 37, 125–127 (2005). [DOI] [PubMed] [Google Scholar]
- 11.Rohmann E. et al. Mutations in different components of FGF signaling in LADD syndrome. Nat Genet 38, 414–417 (2006). [DOI] [PubMed] [Google Scholar]
- 12.Makarenkova H. P. et al. FGF10 is an inducer and Pax6 a competence factor for lacrimal gland development. Development 127, 2563–2572 (2000). [DOI] [PubMed] [Google Scholar]
- 13.Pan Y. et al. Bud specific N-sulfation of heparan sulfate regulates Shp2-dependent FGF signaling during lacrimal gland induction. Development 135, 301–310, doi:dev.014829 [pii] 10.1242/dev.014829 (2008). [DOI] [PubMed] [Google Scholar]
- 14.Zhang Y. et al. Mastermind-like transcriptional co-activator-mediated Notch signaling is indispensable for maintaining conjunctival epithelial identity. Development 140, 594–605, doi: 10.1242/dev.082842 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Aakalu V. K. et al. Human Lacrimal Gland Gene Expression. PLoS One 12, e0169346, doi: 10.1371/journal.pone.0169346 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Dean C., Ito M., Makarenkova H. P., Faber S. C. & Lang R. A. Bmp7 regulates branching morphogenesis of the lacrimal gland by promoting mesenchymal proliferation and condensation. Development 131, 4155–4165 (2004). [DOI] [PubMed] [Google Scholar]
- 17.Dean C. H. et al. Canonical Wnt signaling negatively regulates branching morphogenesis of the lung and lacrimal gland. Dev Biol 286, 270–286 (2005). [DOI] [PubMed] [Google Scholar]
- 18.Wang Q. et al. Lacrimal gland budding requires PI3K-dependent suppression of EGF signaling. Sci Adv 7, doi: 10.1126/sciadv.abf1068 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Garg A. et al. Alx4 relays sequential FGF signaling to induce lacrimal gland morphogenesis. PLoS Genet 13, e1007047, doi: 10.1371/journal.pgen.1007047 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Garg A. et al. FGF-induced Pea3 transcription factors program the genetic landscape for cell fate determination. PLoS Genet 14, e1007660, doi: 10.1371/journal.pgen.1007660 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Li P. et al. alphaE-catenin inhibits a Src-YAP1 oncogenic module that couples tyrosine kinases and the effector of Hippo signaling pathway. Genes Dev 30, 798–811, doi: 10.1101/gad.274951.115 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Ege N. et al. Quantitative Analysis Reveals that Actin and Src-Family Kinases Regulate Nuclear YAP1 and Its Export. Cell Syst 6, 692–708 e613, doi: 10.1016/j.cels.2018.05.006 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Rosenbluh J. et al. beta-Catenin-driven cancers require a YAP1 transcriptional complex for survival and tumorigenesis. Cell 151, 1457–1473, doi: 10.1016/j.cell.2012.11.026 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Zhao D., Yin Z., Soellner M. B. & Martin B. R. Scribble sub-cellular localization modulates recruitment of YES1 to regulate YAP1 phosphorylation. Cell Chem Biol 28, 1235–1241 e1235, doi: 10.1016/j.chembiol.2021.02.019 (2021). [DOI] [PubMed] [Google Scholar]
- 25.Delcroix V. et al. The First Transcriptomic Atlas of the Adult Lacrimal Gland Reveals Epithelial Complexity and Identifies Novel Progenitor Cells in Mice. Cells 12, doi: 10.3390/cells12101435 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Rattner A., Heng J. S., Winer B. L., Goff L. A. & Nathans J. Normal and Sjogren’s syndrome models of the murine lacrimal gland studied at single-cell resolution. Proc Natl Acad Sci U S A 120, e2311983120, doi: 10.1073/pnas.2311983120 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Farmer D. T. et al. Defining epithelial cell dynamics and lineage relationships in the developing lacrimal gland. Development 144, 2517–2528, doi: 10.1242/dev.150789 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Angerer P. et al. destiny: diffusion maps for large-scale single-cell data in R. Bioinformatics 32, 1241–1243, doi: 10.1093/bioinformatics/btv715 (2016). [DOI] [PubMed] [Google Scholar]
- 29.Bravo Gonzalez-Blas C. et al. SCENIC+: single-cell multiomic inference of enhancers and gene regulatory networks. Nat Methods 20, 1355–1367, doi: 10.1038/s41592-023-01938-4 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Ma S., Meng Z., Chen R. & Guan K. L. The Hippo Pathway: Biology and Pathophysiology. Annu Rev Biochem, doi: 10.1146/annurev-biochem-013118-111829 (2018). [DOI] [PubMed] [Google Scholar]
- 31.Pan D. The unfolding of the Hippo signaling pathway. Dev Biol 487, 1–9, doi: 10.1016/j.ydbio.2022.04.001 (2022). [DOI] [PubMed] [Google Scholar]
- 32.Piccolo S., Panciera T., Contessotto P. & Cordenonsi M. YAP/TAZ as master regulators in cancer: modulation, function and therapeutic approaches. Nat Cancer 4, 9–26, doi: 10.1038/s43018-022-00473-z (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Wang Y. et al. Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer. Cell reports 25, 1304–1317 e1305, doi: 10.1016/j.celrep.2018.10.001 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Habbe N. et al. Spontaneous induction of murine pancreatic intraepithelial neoplasia (mPanIN) by acinar cell targeting of oncogenic Kras in adult mice. Proc Natl Acad Sci U S A 105, 18913–18918, doi: 10.1073/pnas.0810097105 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Grcevic D. et al. In vivo fate mapping identifies mesenchymal progenitor cells. Stem Cells 30, 187–196, doi: 10.1002/stem.780 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Jiang M. et al. Transitional basal cells at the squamous-columnar junction generate Barrett’s oesophagus. Nature 550, 529–533, doi: 10.1038/nature24269 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Qiu X. et al. Reversed graph embedding resolves complex single-cell trajectories. Nat Methods 14, 979–982, doi: 10.1038/nmeth.4402 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Cotton J. L. et al. YAP/TAZ and Hedgehog Coordinate Growth and Patterning in Gastrointestinal Mesenchyme. Dev Cell 43, 35–47 e34, doi: 10.1016/j.devcel.2017.08.019 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Basova L. et al. Origin and Lineage Plasticity of Endogenous Lacrimal Gland Epithelial Stem/Progenitor Cells. iScience 23, 101230, doi: 10.1016/j.isci.2020.101230 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.McKenzie I. A. et al. Motor skill learning requires active central myelination. Science 346, 318–322, doi: 10.1126/science.1254960 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Kim N. G. & Gumbiner B. M. Adhesion to fibronectin regulates Hippo signaling via the FAK-Src-PI3K pathway. J Cell Biol 210, 503–515, doi: 10.1083/jcb.201501025 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Sun J. et al. A tightly controlled Src-YAP signaling axis determines therapeutic response to dasatinib in renal cell carcinoma. Theranostics 8, 3256–3267, doi: 10.7150/thno.23964 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Elbediwy A. et al. Integrin signalling regulates YAP and TAZ to control skin homeostasis. Development 143, 1674–1687, doi: 10.1242/dev.133728 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Si Y. et al. Src Inhibits the Hippo Tumor Suppressor Pathway through Tyrosine Phosphorylation of Lats1. Cancer research 77, 4868–4880, doi: 10.1158/0008-5472.CAN-17-0391 (2017). [DOI] [PubMed] [Google Scholar]
- 45.Reuven N., Shanzer M. & Shaul Y. Hippo Pathway Regulation by Tyrosine Kinases. Methods Mol Biol 1893, 215–236, doi: 10.1007/978-1-4939-8910-2_17 (2019). [DOI] [PubMed] [Google Scholar]
- 46.Parsons J. T., Horwitz A. R. & Schwartz M. A. Cell adhesion: integrating cytoskeletal dynamics and cellular tension. Nat Rev Mol Cell Biol 11, 633–643, doi: 10.1038/nrm2957 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Birge R. B., Kalodimos C., Inagaki F. & Tanaka S. Crk and CrkL adaptor proteins: networks for physiological and pathological signaling. Cell communication and signaling : CCS 7, 13, doi: 10.1186/1478-811X-7-13 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Hasegawa H. et al. DOCK180, a major CRK-binding protein, alters cell morphology upon translocation to the cell membrane. Mol Cell Biol 16, 1770–1776 (1996). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Oda T. et al. Crkl is the major tyrosine-phosphorylated protein in neutrophils from patients with chronic myelogenous leukemia. J Biol Chem 269, 22925–22928 (1994). [PubMed] [Google Scholar]
- 50.Tanaka S. et al. C3G, a guanine nucleotide-releasing protein expressed ubiquitously, binds to the Src homology 3 domains of CRK and GRB2/ASH proteins. Proc Natl Acad Sci U S A 91, 3443–3447 (1994). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Collins T. N. et al. Crk proteins transduce FGF signaling to promote lens fiber cell elongation. Elife 7, doi: 10.7554/eLife.32586 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.McGarrigle D., Shan D., Yang S. & Huang X. Y. Role of tyrosine kinase Csk in G protein-coupled receptor- and receptor tyrosine kinase-induced fibroblast cell migration. J Biol Chem 281, 10583–10588, doi: 10.1074/jbc.M513002200 (2006). [DOI] [PubMed] [Google Scholar]
- 53.Takatsuka A. et al. Ablation of Csk in neural crest lineages causes corneal anomaly by deregulating collagen fibril organization and cell motility. Dev Biol 315, 474–488, doi: 10.1016/j.ydbio.2008.01.004 (2008). [DOI] [PubMed] [Google Scholar]
- 54.Tan Y. X. et al. Inhibition of the kinase Csk in thymocytes reveals a requirement for actin remodeling in the initiation of full TCR signaling. Nature immunology 15, 186–194, doi: 10.1038/ni.2772 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Dupont S. et al. Role of YAP/TAZ in mechanotransduction. Nature 474, 179–183, doi: 10.1038/nature10137 (2011). [DOI] [PubMed] [Google Scholar]
- 56.Villars A. & Levayer R. Collective effects in epithelial cell death and cell extrusion. Current opinion in genetics & development 72, 8–14, doi: 10.1016/j.gde.2021.09.004 (2022). [DOI] [PubMed] [Google Scholar]
- 57.Ohsawa S., Vaughen J. & Igaki T. Cell Extrusion: A Stress-Responsive Force for Good or Evil in Epithelial Homeostasis. Dev Cell 44, 532, doi: 10.1016/j.devcel.2018.02.007 (2018). [DOI] [PubMed] [Google Scholar]
- 58.Gudipaty S. A. & Rosenblatt J. Epithelial cell extrusion: Pathways and pathologies. Seminars in cell & developmental biology 67, 132–140, doi: 10.1016/j.semcdb.2016.05.010 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Tanimura N. & Fujita Y. Epithelial defense against cancer (EDAC). Semin Cancer Biol 63, 44–48, doi: 10.1016/j.semcancer.2019.05.011 (2020). [DOI] [PubMed] [Google Scholar]
- 60.Luo W. et al. Global impact of oncogenic Src on a phosphotyrosine proteome. J Proteome Res 7, 3447–3460, doi: 10.1021/pr800187n (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Ma X. et al. Characterization of the Src-regulated kinome identifies SGK1 as a key mediator of Src-induced transformation. Nat Commun 10, 296, doi: 10.1038/s41467-018-08154-1 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Chiba T. et al. MDCK cells expressing constitutively active Yes-associated protein (YAP) undergo apical extrusion depending on neighboring cell status. Sci Rep 6, 28383, doi: 10.1038/srep28383 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Sudol M., Chen H. I., Bougeret C., Einbond A. & Bork P. Characterization of a novel protein-binding module--the WW domain. FEBS Lett 369, 67–71 (1995). [DOI] [PubMed] [Google Scholar]
- 64.Koudelkova L., Brabek J. & Rosel D. Src kinase: Key effector in mechanosignalling. Int J Biochem Cell Biol 131, 105908, doi: 10.1016/j.biocel.2020.105908 (2021). [DOI] [PubMed] [Google Scholar]
- 65.Hoj J. P., Mayro B. & Pendergast A. M. A TAZ-AXL-ABL2 Feed-Forward Signaling Axis Promotes Lung Adenocarcinoma Brain Metastasis. Cell reports 29, 3421–3434 e3428, doi: 10.1016/j.celrep.2019.11.018 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Shanzer M., Adler J., Ricardo-Lax I., Reuven N. & Shaul Y. The nonreceptor tyrosine kinase c-Src attenuates SCF(beta-TrCP) E3-ligase activity abrogating Taz proteasomal degradation. Proc Natl Acad Sci U S A 114, 1678–1683, doi: 10.1073/pnas.1610223114 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Park T. J. & Curran T. Crk and Crk-like play essential overlapping roles downstream of disabled-1 in the Reelin pathway. J Neurosci 28, 13551–13562, doi: 10.1523/JNEUROSCI.4323-08.2008 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Pan B. X., Vautier F., Ito W., Bolshakov V. Y. & Morozov A. Enhanced cortico-amygdala efficacy and suppressed fear in absence of Rap1. J Neurosci 28, 2089–2098, doi: 10.1523/JNEUROSCI.5156-07.2008 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Schmedt C. et al. Csk controls antigen receptor-mediated development and selection of T-lineage cells. Nature 394, 901–904, doi: 10.1038/29802 (1998). [DOI] [PubMed] [Google Scholar]
- 70.Ashery-Padan R., Marquardt T., Zhou X. & Gruss P. Pax6 activity in the lens primordium is required for lens formation and for correct placement of a single retina in the eye. Genes Dev 14, 2701–2711 (2000). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Glogauer M. et al. Rac1 deletion in mouse neutrophils has selective effects on neutrophil functions. J Immunol 170, 5652–5657 (2003). [DOI] [PubMed] [Google Scholar]
- 72.Quadros R. M. et al. Easi-CRISPR: a robust method for one-step generation of mice carrying conditional and insertion alleles using long ssDNA donors and CRISPR ribonucleoproteins. Genome Biol 18, 92, doi: 10.1186/s13059-017-1220-4 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Carbe C., Hertzler-Schaefer K. & Zhang X. The functional role of the Meis/Prep-binding elements in Pax6 locus during pancreas and eye development. Dev Biol 363, 320–329, doi: 10.1016/j.ydbio.2011.12.038 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Carbe C. & Zhang X. Lens induction requires attenuation of ERK signaling by Nf1. Hum Mol Genet 20, 1315–1323, doi:ddr014 [pii] 10.1093/hmg/ddr014 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.







